Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan.

<h4>Background</h4>Trustworthy educational information for patients is critical for increasing their knowledge base and preparing them for shared decision making with clinicians. As the internet has become an important source of health information for many patients, the purpose of this s...

Full description

Bibliographic Details
Main Authors: Juan Ignacio Ruiz, Gagandeep Singh, McKenna Erck, Yimin Geng, Maria E Suarez-Almazor, Maria A Lopez-Olivo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0275676
_version_ 1797974339773005824
author Juan Ignacio Ruiz
Gagandeep Singh
McKenna Erck
Yimin Geng
Maria E Suarez-Almazor
Maria A Lopez-Olivo
author_facet Juan Ignacio Ruiz
Gagandeep Singh
McKenna Erck
Yimin Geng
Maria E Suarez-Almazor
Maria A Lopez-Olivo
author_sort Juan Ignacio Ruiz
collection DOAJ
description <h4>Background</h4>Trustworthy educational information for patients is critical for increasing their knowledge base and preparing them for shared decision making with clinicians. As the internet has become an important source of health information for many patients, the purpose of this study was to assess the quality and content of websites with educational content about immune checkpoint inhibitors.<h4>Methods</h4>We performed an environmental scan of the currently available websites providing educational information for patients about immune checkpoint inhibitors. We used three search engines: Google, Bing, and Yahoo! (9/20/2021). Two independent investigators selected relevant uniform resource locators (URLs), appraised the quality of the websites, and collected their characteristics. We evaluated the accuracy, completeness, technical elements, design and aesthetics, readability, usability, and accessibility of the websites. The user experience was also evaluated.<h4>Results</h4>We identified 37 websites for analysis. In 10 websites (27%), it was not possible to know the source of the information provided. Thirty-three (89%) provided a definition with a simple explanation of cancer and treatment and 30 (81%) on complications of immune checkpoint inhibitors; only seven (19%) provided information about the balance between risks and benefits. Thirty-five (95%) provided a statement of purpose. Regarding the design, all 37 (100%) had appropriate visual aspects, typography, and grammar. Thirty-six (97%) were well organized. For most of the websites (n = 35, 95%) the content was easy to find. Only two websites had a readability score of 6, while the others had higher scores. Regarding the user experience, the overall quality of websites was rated as excellent in 16 (43%), good in 14 (38%), and fair in 7 (19%).<h4>Conclusions</h4>Our findings reveal that websites with information about immune checkpoint inhibitors mostly have general information about cancer, the treatments, and adverse events. Few websites provide information about the balance between harms and benefits of treatment, costs, the source of the information, or the hierarchy of evidence. These findings identify the gap in the quality and content of websites for patients treated with immune checkpoint inhibitors and can help website creators and developers.
first_indexed 2024-04-11T04:18:29Z
format Article
id doaj.art-6e213cb115694acebee3b3a5b9137484
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-11T04:18:29Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-6e213cb115694acebee3b3a5b91374842022-12-31T05:32:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-011710e027567610.1371/journal.pone.0275676Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan.Juan Ignacio RuizGagandeep SinghMcKenna ErckYimin GengMaria E Suarez-AlmazorMaria A Lopez-Olivo<h4>Background</h4>Trustworthy educational information for patients is critical for increasing their knowledge base and preparing them for shared decision making with clinicians. As the internet has become an important source of health information for many patients, the purpose of this study was to assess the quality and content of websites with educational content about immune checkpoint inhibitors.<h4>Methods</h4>We performed an environmental scan of the currently available websites providing educational information for patients about immune checkpoint inhibitors. We used three search engines: Google, Bing, and Yahoo! (9/20/2021). Two independent investigators selected relevant uniform resource locators (URLs), appraised the quality of the websites, and collected their characteristics. We evaluated the accuracy, completeness, technical elements, design and aesthetics, readability, usability, and accessibility of the websites. The user experience was also evaluated.<h4>Results</h4>We identified 37 websites for analysis. In 10 websites (27%), it was not possible to know the source of the information provided. Thirty-three (89%) provided a definition with a simple explanation of cancer and treatment and 30 (81%) on complications of immune checkpoint inhibitors; only seven (19%) provided information about the balance between risks and benefits. Thirty-five (95%) provided a statement of purpose. Regarding the design, all 37 (100%) had appropriate visual aspects, typography, and grammar. Thirty-six (97%) were well organized. For most of the websites (n = 35, 95%) the content was easy to find. Only two websites had a readability score of 6, while the others had higher scores. Regarding the user experience, the overall quality of websites was rated as excellent in 16 (43%), good in 14 (38%), and fair in 7 (19%).<h4>Conclusions</h4>Our findings reveal that websites with information about immune checkpoint inhibitors mostly have general information about cancer, the treatments, and adverse events. Few websites provide information about the balance between harms and benefits of treatment, costs, the source of the information, or the hierarchy of evidence. These findings identify the gap in the quality and content of websites for patients treated with immune checkpoint inhibitors and can help website creators and developers.https://doi.org/10.1371/journal.pone.0275676
spellingShingle Juan Ignacio Ruiz
Gagandeep Singh
McKenna Erck
Yimin Geng
Maria E Suarez-Almazor
Maria A Lopez-Olivo
Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan.
PLoS ONE
title Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan.
title_full Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan.
title_fullStr Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan.
title_full_unstemmed Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan.
title_short Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan.
title_sort quality and content evaluation of websites with information about immune checkpoint inhibitors an environmental scan
url https://doi.org/10.1371/journal.pone.0275676
work_keys_str_mv AT juanignacioruiz qualityandcontentevaluationofwebsiteswithinformationaboutimmunecheckpointinhibitorsanenvironmentalscan
AT gagandeepsingh qualityandcontentevaluationofwebsiteswithinformationaboutimmunecheckpointinhibitorsanenvironmentalscan
AT mckennaerck qualityandcontentevaluationofwebsiteswithinformationaboutimmunecheckpointinhibitorsanenvironmentalscan
AT yimingeng qualityandcontentevaluationofwebsiteswithinformationaboutimmunecheckpointinhibitorsanenvironmentalscan
AT mariaesuarezalmazor qualityandcontentevaluationofwebsiteswithinformationaboutimmunecheckpointinhibitorsanenvironmentalscan
AT mariaalopezolivo qualityandcontentevaluationofwebsiteswithinformationaboutimmunecheckpointinhibitorsanenvironmentalscan